These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin]. Schaefer RM Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139 [No Abstract] [Full Text] [Related]
25. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis]. von Appen K; Klinkmann H Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771 [No Abstract] [Full Text] [Related]
30. Effect of erythropoietin administration in uremia. Gurland HJ; Samtleben W; Schmidt B Contrib Nephrol; 1989; 70():172-7. PubMed ID: 2670428 [No Abstract] [Full Text] [Related]
31. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis]. Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460 [TBL] [Abstract][Full Text] [Related]
32. Restless legs syndrome (RLS) in uremic patients is related to the frequency of hemodialysis sessions. Huiqi Q; Shan L; Mingcai Q Nephron; 2000 Dec; 86(4):540. PubMed ID: 11124621 [No Abstract] [Full Text] [Related]
33. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia]. Stojimirović B; Grujić-Adanja G Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238 [TBL] [Abstract][Full Text] [Related]
34. Erythropoietin may improve the ultrafiltration in peritoneal dialysis: a case report. Gloor HJ; Tosi G Perit Dial Int; 1990; 10(4):306-7. PubMed ID: 2096935 [No Abstract] [Full Text] [Related]
35. Effects of long-term treatment with human recombinant erythropoietin in patients on CAPD. Steinhauer HB Adv Exp Med Biol; 1989; 260():157-65. PubMed ID: 2624242 [No Abstract] [Full Text] [Related]
36. Intravenous immunoglobulins modify the response to erythropoietin in a CAPD patient. al Shohaib S; Abunijem Z Nephron; 1996; 73(4):720. PubMed ID: 8856284 [No Abstract] [Full Text] [Related]
37. [Comparison of the ability to control anemia in patients on hemodialysis and peritoneal dialysis considering iron reserves and plasma erythropoietin]. Majdan M; Ksiazek A; Spasiewicz D Pol Arch Med Wewn; 1996 Apr; 95(4):307-12. PubMed ID: 8755836 [TBL] [Abstract][Full Text] [Related]
38. rHuEpo-resistant anaemia in haemodialysis patients. Ozono Y; Harada T; Taura K; Kawatomi M; Hara K Nephrol Dial Transplant; 1994; 9(7):872-4. PubMed ID: 7970133 [No Abstract] [Full Text] [Related]
39. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient. Hussein MM; Mooij JM; Roujouleh H Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713 [No Abstract] [Full Text] [Related]
40. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia. Binkley LS Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]